Scientific evidence

Impact of gene expression profile testing on the management of squamous cell carcinoma by dermatologists

Oct 2019

To determine the impact of cSCC-GEP test results on management decisions made by dermatologists for cSCC patients.

Author: Teplitz R, et al.

Publication: JDD

Evaluation of additional spatial and temporal information increases the overall accuracy of an objective risk prediction assay in patients with non-dysplastic Barrett’s esophagus

Oct 2019

TissueCypher may be an effective solution to aid decision-making on surveillance intervals and therapeutic interventions in the management of NDBE patients.

Author: Frei N, et al.

Publication: Poster presentation (371) at ACG 2019, San Antonio

An automated, quantitative multiplex immunofluorescence assay accurately risk stratifies Barrett’s esophagus patients with a community-based diagnosis of low grade dysplasia at a rate comparable to expert pathologists

Oct 2019

 

TissueCypher risk stratified BE patients with a community-based diagnosis of LGD with an accuracy comparable to three renowned expert pathologists.

 

Author: Frei N, et al.

Publication: Poster presentation (372) at ACG 2019, San Antonio

Appropriate use criteria for the integration of diagnostic and prognostic gene expression profile assays into the management of cutaneous malignant melanoma: an expert panel consensus-based modified delphi process assessment

Sep 2019

Expert panel of 9 dermatologists developed 29 clinical scenarios creating an evidence based framework for AUC recommendations for integration of melanoma GEP tests into clincial practice.

Author: Berman B, et al.

Publication: SKIN: Journal of Cutaneous Melanoma

Level of evidence review for a gene expression profile test for cutaneous melanoma

Jul 2019

Review the current literature and establish the level of evidence for a cutaneous melanoma 31-GEP test.

Author: Dubin D, et al.

Publication: American Journal of Clinical Dermatology

Establishing an evidence-based decision point for clinical use of the 31-gene expression profile test in cutaneous melanoma

Jul 2019

Multi center study establishing appropriate use criteria for determining risk of recurrence in patients with tumors >0.3mm in thickness.

Author: Marks E, et al.

Publication: SKIN: Journal of Cutaneous Melanoma

Independent validation of a tissue systems pathology test to predict progression in Barrett’s esophagus patients

May 2019

TissueCypher identifies NDBE patients who are at increased risk for progression to HGD/EAC and may benefit from increased surveillance or early intervention.

Author: Davison J, et al.

Publication: Podium presentation (1068) at DDW 2019, San Diego

Prospective validation of the prognostic 31-gene expression profiling test in primary cutaneous melanoma

Apr 2019

Independent, prospective study with over 3.5 years of follow-up, showing results consistent with previous validation studies with GEP class score as statistically associated with MSS, DMFS and RFS.

Author: Keller J, et al.

Publication: Cancer Medicine

Correlation of melanoma gene expression score with clinical outcomes on a series of melanocytic lesions

Apr 2019

Clinical validation study of the 23-GEP in lesions with clinical outcomes and follow-up data.

Author: Ko J, et al.

Publication: Human Pathology

Next-generation sequencing of uveal melanoma for detection of genetic alterations predicting metastasis

Apr 2019

Purpose: To clinically use the UCSF500, a pancancer, next-generation sequencing assay in uveal melanoma (UM) and to correlate results with gene expression profiling (GEP) and predictive factors for metastasis.

Author: Afshar A, et al.

Publication: Translational Vision Science & Technology

Early outcome of a 31-gene expression profile test in 86 AJCC stage IB-II melanoma patients

Jan 2019

A prospective multicentre cohort study.  Multicentre evaluation the early prognostic performance of a genetic signature in a multicentre prospectively evaluated cohort.

Author: Podlipnik S, et al.

Publication: Journal of the European Academy of Dermatology and Venereology

Performance of a 31-gene expression profile test in cutaneous melanomas of the head and neck

Jan 2019

Gene expression profile class and node status stratified tumors into significantly different 5-year survival groups by Kaplan-Meier method and both were independent predictors of recurrence in multivariate analysis.

Author: Gastman B, et al.

Publication: Head and Neck